Status:
COMPLETED
Body Fat Mass Association With Clinical Metabolic Profiles, Markers of Inflammation and Adipocytokines
Lead Sponsor:
Tungs' Taichung Metroharbour Hospital
Conditions:
Overweight and Obesity
Eligibility:
All Genders
20-100 years
Brief Summary
Overweight and obesity have become an increasing problem in patients on hemodialysis. However, in virtually all observational studies in chronic kidney disease(CKD) and dialysis patients , using body ...
Detailed Description
Patient Selection Clinically stable stage 5 chronic kidney disease patients (400 patients) attending the Tungs Taichung Metroharbour will be enrolled in this study. These patients will be given writt...
Eligibility Criteria
Inclusion
- Both sexes aged \> 20 years-old. Received stable hemodialysis at least 3 months. Written informed consent.
Exclusion
- Patients with malignant disease, acute infectious disease, acute inflammatory disease (such as collagen disease), and advanced liver disease are excluded.
Key Trial Info
Start Date :
March 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
65 Patients enrolled
Trial Details
Trial ID
NCT02799719
Start Date
March 1 2014
End Date
December 1 2016
Last Update
February 20 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.